Request Free Sample
×
Psoriasis Biosimilar Market
ID: MRFR/HC/35777-HCR
128 Pages
October 2025
Rapport d’étude de marché sur les biosimilaires du psoriasis par type de produits biologiques (anticorps monoclonaux, protéines de fusion, protéines recombinantes), par voie d’administration (sous-cutanée, intraveineuse, orale), par type de maladie (psoriasis en plaques, psoriasis en gouttes, psoriasis inverse, psoriasis pustuleux), par canal de distribution (pharmacies hospitalières, pharmacies de détail, pharmacies en ligne) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie-Pacifique, Moyen-Orient et Afrique) - Prévisions jusq... lire la suite
Les principales entreprises du marché Psoriasis Biosimilar Market incluent
Portée du rapport
FAQs
What is the current valuation of the Psoriasis Biosimilar Market as of 2024?
The Psoriasis Biosimilar Market was valued at 4.211 USD Billion in 2024.
What is the projected market size for the Psoriasis Biosimilar Market by 2035?
The market is projected to reach 11.79 USD Billion by 2035.
What is the expected CAGR for the Psoriasis Biosimilar Market during the forecast period 2025 - 2035?
The expected CAGR for the market during 2025 - 2035 is 9.81%.
Which companies are considered key players in the Psoriasis Biosimilar Market?
Key players include Amgen, Sandoz, Mylan, Boehringer Ingelheim, Pfizer, Samsung Bioepis, Novartis, Teva, and Eisai.
What are the main segments of the Psoriasis Biosimilar Market?
The main segments include Biologics Type, Administration Route, Disease Type, and Distribution Channel.
How does the market for Monoclonal Antibodies compare to other biologics types?
The market for Monoclonal Antibodies was valued at 1.684 USD Billion in 2024 and is projected to grow to 4.67 USD Billion by 2035.
What is the projected market size for Plaque Psoriasis by 2035?
The market for Plaque Psoriasis is expected to grow from 2.1 USD Billion in 2024 to 5.8 USD Billion by 2035.
Which administration route is anticipated to have the highest market growth?
The Subcutaneous administration route, valued at 1.684 USD Billion in 2024, is projected to reach 4.67 USD Billion by 2035.
What distribution channel is expected to show significant growth in the Psoriasis Biosimilar Market?
Online Pharmacies, valued at 1.264 USD Billion in 2024, are expected to grow to 3.62 USD Billion by 2035.
How does the market for Guttate Psoriasis compare to other disease types?
The market for Guttate Psoriasis was valued at 0.9 USD Billion in 2024 and is projected to grow to 2.5 USD Billion by 2035.
Télécharger l'échantillon gratuit
Veuillez remplir le formulaire ci-dessous pour recevoir un échantillon gratuit de ce rapport
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Étude de cas
Aerospace & Defense
Laisser un commentaire